HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME
HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME
批准号:
6182575
负责人:
BOYD E METZGER
金额:
$191.79万
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-05-04 至 2004-03-31
关键词:
clinical research cooperative study disease /disorder proneness /risk epidemiology female gestational diabetes mellitus glucose tolerance human birth weight human pregnant subject human subject hyperglycemia hyperinsulinism hypoglycemia labor complications newborn human (0-6 weeks) pregnancy women's health
中文摘要
已有共识认为,显性糖尿病(DM),无论是否伴有代谢失调的症状或体征,都与不良妊娠结局的显著风险有关。另一方面,与葡萄糖不耐受程度没有明显的糖尿病严重相关的不良结果的风险是有争议的。高血糖和不良妊娠结局(HAPO)研究是一项基本的流行病学调查,旨在澄清妊娠晚期不同水平的葡萄糖耐量与不良结局风险之间的关系。它的总体目标是通过一项涉及16个现场中心和大约25,000名孕妇的国际合作研究,在怀孕期间使母亲、胎儿和新生儿面临更高风险的血糖水平方面取得重大进展。基本的假设是,高血糖,没有明显的糖尿病严重,与母亲、胎儿和新生儿不良结局的风险增加有关,这与代谢紊乱的程度独立相关。HAPO的具体目标是:1.在医学照顾者对糖耐量状况“视而不见”的情况下,对妊娠晚期的大型、异质性、多民族、多文化、不同种族的妇女进行糖耐量检查(除非在空腹和/或两小时OGTT血糖浓度超过预先定义的临界值的情况下除外);以及2.提供可用于得出国际上可接受的妊娠期糖尿病(GDM)诊断和分类标准的数据,该标准基于对妊娠特定不良后果风险的识别。这项研究将在妊娠晚期(包括OGTT)和分娩时收集关于妇女的高质量标准化数据,以评估不良结果,包括胎儿高胰岛素血症、胎儿肥胖(巨大儿)、手术分娩(剖腹产)和新生儿发病率(低血糖)。HAPO将包括研究参与者的现场中心和区域中心,位于芝加哥西北大学医学院的临床协调中心和数据协调中心,以及位于北爱尔兰贝尔法斯特的中心实验室。该应用程序请求为临床协调中心、外地和区域中心以及中心实验室提供支持。通过非美国中心的同事分担费用,HAPO研究的成本效益得到了提高。
英文摘要
There is a consensus that overt diabetes mellitus (DM), whether or not accompanied by symptoms or signs of metabolic decompensation, is associated with a significant risk of adverse pregnancy outcome. On the other hand, the risk of adverse outcome associated with degrees of glucose intolerance less severe than overt DM is controversial. The Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study is a basic epidemiologic investigation aiming to clarify unanswered questions on the association of various levels of glucose intolerance during the third trimester of pregnancy and risk of adverse outcomes. Its General Aim, by means of an international cooperative study involving 16 field centers and approximately 25,000 pregnant women, is to achieve a major advance in knowledge on levels of glucose during pregnancy that place the mother, fetus, and neonate at increased risk. The primary hypothesis is that hyperglycemia, less severe than overt DM, is associated with increased risk of adverse maternal, fetal, and neonatal outcome that is independently related to the degree of metabolic disturbance. Specific Aims of HAPO are: 1. To examine glucose tolerance in a large, heterogeneous, multinational, multicultural, ethnically diverse cohort of women in the third trimester of gestation with medical caregivers "blinded" to status of glucose tolerance (except in those instances where fasting and/or two hour OGTT plasma glucose concentration exceeds a predefined cutoff value); and 2. To provide data that can be used to derive internationally acceptable criteria for the diagnosis and classification of gestational diabetes mellitus (GDM) based on the identification of pregnancies at risk for specific adverse outcomes. The study is to be accomplished with high quality standardized data collection on the women during the third trimester of gestation (including the OGTT) and at time of delivery for assessment of adverse outcomes, including fetal hyperinsulinism, fetal obesity (macrosomia), operative delivery (caesarian section), and neonatal morbidity (hypoglycemia). HAPO is to include field centers and regional centers where the participants will be studied, a Clinical Coordinating Center and Data Coordinating Center, both located at the Northwestern University Medical School in Chicago, as well as a Central Laboratory located in Belfast, Northern Ireland. This application requests support for the Clinical Coordinating Center, the field and regional centers and Central Laboratory. Cost effectiveness for the HAPO study is enhanced through cost sharing by colleagues in non-U.S. centers.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyperglycemia and Pregnancy Outcome(HAPO)Follow Up Study
-
批准号:8537071
-
项目类别:
-
资助金额:$5.69万
-
财政年份:2012
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Pregnancy Outcome(HAPO)Follow Up Study
-
批准号:8456907
-
项目类别:
-
资助金额:$432.58万
-
财政年份:2012
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Pregnancy Outcome (HAPO) Follow Up Study
-
批准号:8733378
-
项目类别:
-
资助金额:$14.45万
-
财政年份:2012
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Pregnancy Outcome(HAPO) Follow Up Study
-
批准号:8636468
-
项目类别:
-
资助金额:$445.32万
-
财政年份:2012
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Pregnancy Outcome(HAPO)Follow Up Study
-
批准号:8277164
-
项目类别:
-
资助金额:$481.04万
-
财政年份:2012
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Pregnancy Outcome(HAPO) Follow Up Study
-
批准号:8912577
-
项目类别:
-
资助金额:$6.81万
-
财政年份:2012
-
负责人:BOYD E METZGER
-
依托单位:
Concentration of Blood B-Hydroxylbutyrate in Normal and Diabetic Pregnancy
-
批准号:7040359
-
项目类别:
-
资助金额:$0.72万
-
财政年份:2003
-
负责人:BOYD E METZGER
-
依托单位:
HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME
-
批准号:6520998
-
项目类别:
-
资助金额:$188.9万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME
-
批准号:2745557
-
项目类别:
-
资助金额:$86.64万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
-
批准号:7052820
-
项目类别:
-
资助金额:$235.47万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
-
批准号:6881652
-
项目类别:
-
资助金额:$230.52万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME
-
批准号:6636926
-
项目类别:
-
资助金额:$50.18万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
-
批准号:8106567
-
项目类别:
-
资助金额:$50.0万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
-
批准号:6682946
-
项目类别:
-
资助金额:$239.72万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
Hyperglycemia and Adverse Pregnancy Outcome (HAPO)
-
批准号:7196502
-
项目类别:
-
资助金额:$193.65万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
HYPERGLYCEMIA AND ADVERSE PREGNANCY OUTCOME
-
批准号:6387808
-
项目类别:
-
资助金额:$235.36万
-
财政年份:1999
-
负责人:BOYD E METZGER
-
依托单位:
PROSPECTIVE PHYSIOLOGICAL AND PSYCHOLOGICAL FOLLOW-UP OF OFFSPRING OF DIABETICS
-
批准号:6245142
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:BOYD E METZGER
-
依托单位:
GENETIC AND PHENOTYPIC FEATURES OF NIDDM IN FAMILIES
-
批准号:6245192
-
项目类别:
-
资助金额:$1.2万
-
财政年份:1997
-
负责人:BOYD E METZGER
-
依托单位:
PROSPECTIVE PHYSIOLOGICAL AND PSYCHOLOGICAL FOLLOW-UP OF OFFSPRING OF DIABETICS
-
批准号:6275276
-
项目类别:
-
资助金额:$2.26万
-
财政年份:1997
-
负责人:BOYD E METZGER
-
依托单位:
PRIMARY PREVENTION TRIAL (DPT-2)
-
批准号:2148633
-
项目类别:
-
资助金额:$21.75万
-
财政年份:1994
-
负责人:BOYD E METZGER
-
依托单位:
海外基金